A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidradenitis suppurativa

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 28a9527686ffd4483aefc7b45f5164395dae372c
First added on: Oct 09, 2026